IRIS
Paciotti, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.469
NA - Nord America 1.701
SA - Sud America 745
EU - Europa 443
AF - Africa 70
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.611
SG - Singapore 1.380
BR - Brasile 583
CN - Cina 430
VN - Vietnam 381
IT - Italia 75
AR - Argentina 73
HK - Hong Kong 70
FI - Finlandia 51
DE - Germania 50
FR - Francia 47
GB - Regno Unito 46
IE - Irlanda 42
IN - India 38
CA - Canada 34
BD - Bangladesh 33
MX - Messico 33
EC - Ecuador 31
ID - Indonesia 27
NG - Nigeria 21
RU - Federazione Russa 20
NL - Olanda 19
ZA - Sudafrica 18
IQ - Iraq 16
UA - Ucraina 15
VE - Venezuela 14
CO - Colombia 13
PK - Pakistan 11
SE - Svezia 11
AT - Austria 10
CL - Cile 10
TR - Turchia 10
PL - Polonia 9
PY - Paraguay 9
AU - Australia 8
JP - Giappone 8
MO - Macao, regione amministrativa speciale della Cina 8
UY - Uruguay 8
ES - Italia 7
TN - Tunisia 7
CH - Svizzera 6
EG - Egitto 6
MY - Malesia 6
UZ - Uzbekistan 6
DZ - Algeria 5
JM - Giamaica 5
NP - Nepal 5
RO - Romania 5
SA - Arabia Saudita 5
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IL - Israele 4
JO - Giordania 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
LT - Lituania 2
PH - Filippine 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
KW - Kuwait 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 5.438
Salva come PNG Salva come JPEG
Città #
Singapore 438
Ashburn 238
San Jose 210
Dallas 167
Beijing 136
Ho Chi Minh City 134
The Dalles 117
Hanoi 89
Shanghai 79
Wilmington 73
Hong Kong 63
New York 63
Chandler 62
Helsinki 51
Los Angeles 45
Dublin 43
São Paulo 41
San Mateo 39
Santa Clara 38
Ann Arbor 31
Milan 29
Boardman 28
Lawrence 24
Paris 24
Princeton 24
Rio de Janeiro 24
Da Nang 22
Benin City 21
Orem 18
Haiphong 16
Leawood 16
Mexico City 15
Guayaquil 14
Buffalo 13
Hải Dương 13
Amsterdam 12
Camden 12
Montreal 12
Belo Horizonte 11
Johannesburg 11
London 11
Seattle 11
Thái Bình 10
Brasília 9
Brooklyn 9
Curitiba 9
Fairfield 9
Naples 9
Toronto 9
Warsaw 9
Buenos Aires 8
Frankfurt am Main 8
Phoenix 8
Porto Alegre 8
Biên Hòa 7
Chicago 7
Goiânia 7
Manaus 7
Quito 7
Salvador 7
Montevideo 6
Osasco 6
Woodbridge 6
Asunción 5
Baghdad 5
Campinas 5
Charlotte 5
Chennai 5
Feira de Santana 5
Guarulhos 5
Hortolândia 5
Istanbul 5
Manchester 5
Mumbai 5
Nuremberg 5
Phủ Lý 5
São Gonçalo 5
São José do Rio Preto 5
Tashkent 5
Tokyo 5
Uberlândia 5
Amman 4
Atlanta 4
Baku 4
Boston 4
Bến Tre 4
Cairo 4
Can Tho 4
Caxias do Sul 4
Council Bluffs 4
Erbil 4
Jakarta 4
Juiz de Fora 4
Kuala Lumpur 4
Kyiv 4
Londrina 4
Mogi das Cruzes 4
Moscow 4
New Delhi 4
New Haven 4
Totale 2.869
Salva come PNG Salva come JPEG
Nome #
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 112
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 99
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 89
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 88
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 86
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 85
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 84
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 83
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 82
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 81
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 78
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 77
Effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy: A randomized controlled trial 71
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 71
External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era 69
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis 69
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer 68
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies 67
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study 66
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma 65
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging 64
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience 63
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 62
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes 61
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer 59
Gender-specific risk factors for renal cell carcinoma: a systematic review 58
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story 58
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology 57
ROBOT-ASSISTED PARTIAL NEPHRECTOMY: TECHNIQUES AND OUTCOMES FROM THE TRANSATLANTIC ROBOTIC NEPHRON-SPARING SURGERY (TRONES) STUDY GROUP 57
En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study 57
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer in the initial biopsy setting 56
IN VITRO AND IN VIVO NEW EVIDENCE FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE: OPTIMIZATION OF THE STONE FREE RATE (SFR) AFTER RIRS 56
A cost analysis in implementing simulation-based training into a novel urology curriculum 55
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? 54
Assessment of the diagnostic accuracy of microultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional preliminary experience 53
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer 53
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study 52
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? 52
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis 52
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure 51
Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer 50
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial 50
Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy 50
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study 49
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis 47
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity 46
New horizons in gynecological surgery: first-year experience with HUGO™ robotic-assisted surgery system at two tertiary referral robotic centers 46
Reply by Authors 45
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancer 44
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration 44
Assessment of face and content validity of performance metrics for basic robotic surgery skills PBP curriculum: a J-ERUS/YAU consensus on dry-lab training models 44
A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer 44
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes 44
THE UTILITY OF MICRO-ULTRASOUND IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: A PRIAS STUDY EXTENSION 44
Comparison between the diagnostic accuracy of high resolution micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Preliminary results from a single-institutional ongoing prospective trial 43
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional experience 43
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer 42
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center 42
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers 42
Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study 41
High resolution micro-ultrasound imaging for bladder cancer: A gender and stage-oriented assessment. VIDEO 40
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy 40
Profiling of the immune microenvironment in prostate cancer at single cell level 40
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic 40
Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment? 40
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 39
Will Renorrhaphy Become Obsolete? Evaluation of a New Hemostatic Sealant 39
HEAD-TO-HEAD COMPARISON BETWEEN MICRO-ULTRASOUND AND MRI IN THE DIFFERENTIATION BETWEEN MUSCLE-INVASIVE AND NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM THE BLADDER MICROUS VERSUS MRI CANCER IMAGING STAGING STUDY (BUS-MISS) PROTOCOL 39
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 39
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers 39
Surgical Complications Requiring Intervention in Open versus Minimally Invasive Radical Prostatectomy 38
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride 38
Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study 38
Current Landscape of Surgical Assessment Models in Urology Residency Training. Letter 37
MP36-20 POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER 37
Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots 36
Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades 35
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative study 35
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis 35
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system 35
Beyond the price tag: reassessing the value of robotic surgery in urologic oncology 34
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion 34
Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis 34
A comparative analysis of the HUGOTM robot-assisted surgery system and the Da Vinci® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment 34
Machine learning driven diagnostic pathway for clinically significant prostate cancer: the role of micro-ultrasound 33
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer 33
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center 33
Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer 33
Robot-Assisted Sacropexy with the Novel HUGO Robot-Assisted Surgery System: Initial Experience and Surgical Setup at a Tertiary Referral Robotic Center 32
European training in urology (ENTRY): quality-assured training for European urology residents 32
Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center 31
Development and validation of metrics for a new RAPN training model 30
Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection 30
Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center 30
Improving Augmented Reality Through Deep Learning: Real-time Instrument Delineation in Robotic Renal Surgery 30
Transforming hostile abdomen management: the rise of single-port for retroperitoneal robot-assisted partial nephrectomy 30
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical Skills 29
Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy? 29
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma 29
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinoma 29
Totale 5.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022126 2 9 1 23 0 1 7 17 18 12 33 3
2022/2023282 51 4 28 24 23 16 7 19 37 31 35 7
2023/2024279 21 22 55 10 11 44 17 26 2 8 21 42
2024/2025882 19 2 21 15 4 65 35 48 113 143 128 289
2025/20263.838 457 255 363 662 231 164 668 214 235 267 179 143
Totale 5.574